GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Sale Of Property, Plant, Equipment

Roquefort Therapeutics (LSE:ROQ) Sale Of Property, Plant, Equipment : £0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Sale Of Property, Plant, Equipment?

Roquefort Therapeutics's sale of property, plant, equipment for the six months ended in Jun. 2024 was £0.00 Mil. It means Roquefort Therapeutics gained £0.00 Mil from selling property, plant, and equipment. Roquefort Therapeutics's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Jun. 2024 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Dec. 2023 ), Roquefort Therapeutics gained the same money from selling property, plant, and equipment in Jun. 2024 (£0.00 Mil).


Roquefort Therapeutics Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Roquefort Therapeutics's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Sale Of Property, Plant, Equipment Chart

Roquefort Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
- - -

Roquefort Therapeutics Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial - - - - -

Roquefort Therapeutics Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roquefort Therapeutics Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Roquefort Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.

Roquefort Therapeutics Headlines

No Headlines